SAMC
AMRI

Shinko Asset Management Company’s Albany Molecular Research Inc AMRI Stock Holding History

Shinko Asset Management Company’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$2.6M Sell
157,794
-45,656
-22% -$676K 0.02% 151
2016
Q2 		$2.73M Hold
203,450
– – 0.02% 155
2016
Q1 		$3.11M Hold
203,450
– – 0.02% 139
2015
Q4 		$4.04M Buy
203,450
+32,574
+19% +$619K 0.04% 113
2015
Q3 		$2.98M Buy
+170,876
New +$3.48M 0.03% 121

Other funds holding AMRI

PIP
Permian Investment Partners Dallas, Texas $905M AUM 13.43% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
OWP
Obermeyer Wealth Partners Aspen, Colorado $2.44B AUM 24.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ACM
American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return

Shinko Asset Management Company's AMRI Position: Q3 2016 in Review

Shinko Asset Management Company reduced its Albany Molecular Research Inc (AMRI) stake by 22% in Q3 2016, selling an estimated $676K and leaving 157,794 shares worth $2.6M. The position accounts for 0.02% of the portfolio, ranked #151.

Shinko Asset Management Company first reported a position in AMRI in Q3 2015 and has held it in 5 quarters since. The position peaked at $4.04M in Q4 2015. 137 funds tracked by Wall St. Rank hold AMRI as of Q3 2016.

  • Shinko Asset Management Company held 157,794 shares of Albany Molecular Research Inc worth $2.6M as of Q3 2016.
  • Shinko Asset Management Company sold 45,656 Albany Molecular Research Inc shares in Q3 2016, an estimated $676K.
  • Albany Molecular Research Inc made up 0.02% of Shinko Asset Management Company's portfolio in Q3 2016, its #151 holding.
  • Shinko Asset Management Company first reported a position in Albany Molecular Research Inc in Q3 2015 and has held it in 5 quarters since.
  • Shinko Asset Management Company's Albany Molecular Research Inc position peaked at $4.04M in Q4 2015.
  • 137 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2016.

Based on Shinko Asset Management Company's 13F filing for Q3 2016, filed 24 Oct 2016.